GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

BIT:1GILD • US3755581036

128.32 EUR
+7.58 (+6.28%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, 1GILD scores 6 out of 10 in our fundamental rating. 1GILD was compared to 81 industry peers in the Biotechnology industry. 1GILD scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on 1GILD. With these ratings, 1GILD could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year 1GILD was profitable.
  • In the past year 1GILD had a positive cash flow from operations.
  • 1GILD had positive earnings in each of the past 5 years.
  • In the past 5 years 1GILD always reported a positive cash flow from operatings.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • The Return On Assets of 1GILD (13.86%) is better than 88.89% of its industry peers.
  • Looking at the Return On Equity, with a value of 37.80%, 1GILD belongs to the top of the industry, outperforming 97.53% of the companies in the same industry.
  • 1GILD's Return On Invested Capital of 18.54% is amongst the best of the industry. 1GILD outperforms 97.53% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1GILD is above the industry average of 12.03%.
  • The 3 year average ROIC (16.22%) for 1GILD is below the current ROIC(18.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • 1GILD has a better Profit Margin (27.88%) than 86.42% of its industry peers.
  • 1GILD's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1GILD (38.96%) is better than 96.30% of its industry peers.
  • In the last couple of years the Operating Margin of 1GILD has grown nicely.
  • Looking at the Gross Margin, with a value of 78.72%, 1GILD is in the better half of the industry, outperforming 67.90% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1GILD is still creating some value.
  • Compared to 1 year ago, 1GILD has about the same amount of shares outstanding.
  • Compared to 5 years ago, 1GILD has less shares outstanding
  • The debt/assets ratio for 1GILD is higher compared to a year ago.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.56
WACC11.9%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • 1GILD has a Current Ratio of 1.53. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.53, 1GILD is in line with its industry, outperforming 40.74% of the companies in the same industry.
  • A Quick Ratio of 1.17 indicates that 1GILD should not have too much problems paying its short term obligations.
  • 1GILD's Quick ratio of 1.17 is on the low side compared to the rest of the industry. 1GILD is outperformed by 61.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.88% over the past year.
  • The Earnings Per Share has been decreasing by -7.01% on average over the past years.
  • 1GILD shows a small growth in Revenue. In the last year, the Revenue has grown by 2.78%.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.03% on average over the next years. This is quite good.
  • 1GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.65, the valuation of 1GILD can be described as rather expensive.
  • 88.89% of the companies in the same industry are more expensive than 1GILD, based on the Price/Earnings ratio.
  • 1GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
  • Based on the Price/Forward Earnings ratio of 17.12, the valuation of 1GILD can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 88.89% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, 1GILD is valued a bit cheaper.
Industry RankSector Rank
PE 18.65
Fwd PE 17.12
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 85.19% of the companies in the same industry are more expensive than 1GILD, based on the Enterprise Value to EBITDA ratio.
  • 91.36% of the companies in the same industry are more expensive than 1GILD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.9
EV/EBITDA 12.77
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of 1GILD may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1GILD's earnings are expected to grow with 27.78% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y39.1%
EPS Next 3Y27.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • 1GILD has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.64, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 95.06% of the companies listed in the same industry.
  • 1GILD's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • 1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

BIT:1GILD (2/6/2026, 7:00:00 PM)

128.32

+7.58 (+6.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap159.20B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target118.53 (-7.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.67
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)7.54%
PT rev (3m)5.6%
EPS NQ rev (1m)-2.7%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 18.65
Fwd PE 17.12
P/S 6.51
P/FCF 19.9
P/OCF 19.6
P/B 8.83
P/tB N/A
EV/EBITDA 12.77
EPS(TTM)6.88
EY5.36%
EPS(NY)7.5
Fwd EY5.84%
FCF(TTM)6.45
FCFY5.03%
OCF(TTM)6.55
OCFY5.1%
SpS19.7
BVpS14.53
TBVpS-3.27
PEG (NY)0.23
PEG (5Y)N/A
Graham Number47.43
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC11.9%
ROIC/WACC1.56
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.27%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status for 1GILD stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 18.65 and the Price/Book (PB) ratio is 8.83.


What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.